
When it comes to your health you can never be too cautious. Finding lung cancer early, when it is easiest to treat, can save your life.
Early detection of lung cancer is defined as strategies that can detect lung cancer at a stage where surgery or stereotactic body radiation therapy (SBRT) can be offered with the goal of a cure.
There are a number of factors that determine the outlook for any lung cancer patient in addition to when the lung cancer is detected, including the type of lung cancer, the patient’s health in general, and the responsiveness of the patient’s lung cancer to treatment.
However, lung cancer is most easily and effectively treated when it is found at an early stage. Statistically, those with lung cancer caught early on have a much higher likelihood of surviving at least five years after diagnosis than those diagnosed when the lung cancer is more advanced.
Currently, only 17% of lung cancers are diagnosed while the tumor is still localized—that is, only found at the site where it started. This is commonly referred to as stage I. The major challenge is that most people with lung cancer only have symptoms when they are in the later stages of the disease, so lung cancer is not usually suspected and discovered until it has had the chance to grow and spread.
RELATED: 10 Common Factors Increasing Your Risk for Lung Cancer
Lung cancer can be detected early via screening. Screening for lung cancer means checking for cancer before there are any symptoms.
For lung cancer, early-detection screening by a low-dose computed tomography (LDCT) scan (also called low-dose spiral CT scan or helical CT scan) has proven to be effective among individuals considered to be at high risk. It is also only recommended for these individuals.
LDCT is much more sensitive than chest X-rays and can detect smaller abnormalities that may be lung cancer. Chest X-rays are not recommended for lung cancer screening because they often miss early-stage lung cancers and have not resulted in decreased mortality. This is also the case for sputum cytology, a test that checks for abnormal cells in the sputum.
There are several sets of guidelines, including the ones outlined below, to help determine who should be screened by LDCT for lung cancer. These guidelines are primarily based on active (current or prior) tobacco exposure. The guidelines have been established in large part from the results of the National Lung Screening Trial (NLST). They are very similar, with the differences primarily related to the role of screening for the oldest patients and risk factors other than smoking. All of the patients who are recommended for screening are considered to be at high risk for developing lung cancer but do not currently have any symptoms to suggest that they do have lung cancer.
The most common guidelines for annual screening with LDCT is for adults who are:
Patients should discuss these guidelines with their doctor and understand the risks and benefits before undergoing LDCT screening.
RELATED: 5 Ways to Keep Your Lungs Healthy
The NCCN® recommends going to screening centers that:
Despite the benefits of LDCT lung cancer screening, including decreased mortality from lung cancer, decreased mortality from lung cancer treatment, and improved quality of life, there are some drawbacks and risks, including that LDCT may:
In addition:
When weighing whether or not to get an LDCT, it is important to keep in mind that an LDCT can find other abnormal growths in tissues outside the lungs (incidental nonpulmonary findings). These findings need to be followed up on by your doctor or specialist. You can also follow up with your doctor if you have any additional questions.
This content is brought to you by The Lungevity Foundation and the BDO Editorial Staff.

By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.